Terns Pharmaceuticals, Inc.
TERN
$2.92
-$0.13-4.26%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -88.85M | -88.07M | -95.90M | -91.06M | -90.21M |
| Total Depreciation and Amortization | 896.00K | 902.00K | 918.00K | 895.00K | 881.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.56M | 13.42M | 21.60M | 21.00M | 20.46M |
| Change in Net Operating Assets | 4.38M | -1.00M | -5.62M | -6.65M | 1.48M |
| Cash from Operations | -70.02M | -74.75M | -78.99M | -75.81M | -67.39M |
| Capital Expenditure | -42.00K | -86.00K | -94.00K | -81.00K | -52.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -12.37M | 129.26M | 75.20M | -57.84M | -37.94M |
| Cash from Investing | -12.41M | 129.17M | 75.11M | -57.92M | -37.99M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 164.38M | 177.63M | 14.28M | 14.37M | 42.30M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -388.00K | -75.00K | 0.00 | 0.00 | -344.00K |
| Cash from Financing | 164.00M | 177.55M | 14.28M | 14.37M | 41.95M |
| Foreign Exchange rate Adjustments | -56.00K | 268.00K | 181.00K | 101.00K | 117.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 81.51M | 232.24M | 10.58M | -119.26M | -63.31M |